We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: Here's Why
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $278.58, demonstrating a -4.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.07% gain on the day. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq increased by 0.18%.
The largest U.S. health insurer's shares have seen a decrease of 3.15% over the last month, not keeping up with the Medical sector's gain of 2.39% and the S&P 500's gain of 5.71%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 29, 2025. In that report, analysts expect UnitedHealth Group to post earnings of $4.84 per share. This would mark a year-over-year decline of 28.82%. Alongside, our most recent consensus estimate is anticipating revenue of $111.55 billion, indicating a 12.84% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $21.15 per share and a revenue of $448.53 billion, signifying shifts of -23.54% and +12.06%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 4.19% downward. UnitedHealth Group presently features a Zacks Rank of #4 (Sell).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 13.83. This expresses a premium compared to the average Forward P/E of 12.94 of its industry.
We can also see that UNH currently has a PEG ratio of 1.45. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.05 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 237, putting it in the bottom 5% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Sinks As Market Gains: Here's Why
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $278.58, demonstrating a -4.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.07% gain on the day. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq increased by 0.18%.
The largest U.S. health insurer's shares have seen a decrease of 3.15% over the last month, not keeping up with the Medical sector's gain of 2.39% and the S&P 500's gain of 5.71%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 29, 2025. In that report, analysts expect UnitedHealth Group to post earnings of $4.84 per share. This would mark a year-over-year decline of 28.82%. Alongside, our most recent consensus estimate is anticipating revenue of $111.55 billion, indicating a 12.84% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $21.15 per share and a revenue of $448.53 billion, signifying shifts of -23.54% and +12.06%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 4.19% downward. UnitedHealth Group presently features a Zacks Rank of #4 (Sell).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 13.83. This expresses a premium compared to the average Forward P/E of 12.94 of its industry.
We can also see that UNH currently has a PEG ratio of 1.45. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.05 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 237, putting it in the bottom 5% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.